-
Guidelines update Guidelines for Pharmacy Services for Antineoplastic Drugs
Time of Update: 2022-11-25
Summary Antibody drugs are drugs prepared by using antibody engineering technology mainly based on cell and genetic engineering technology, and are widely used in the treatment of malignant tumors. A
-
New Oral Drug May Be Alternative to ESAs for Renal Anemia in Dialysis-Initiating Patients, New Study Shows
Time of Update: 2022-06-18
The study shows that the oral drug Daparodustat is safe and effective, non-inferior to ESAs, and can be used as another powerful tool for intervening renal anemia in patients with initial dialysis² .
Intervention Phase: Patients who successfully pass screening will be randomized 1:1 to Daparodustat and ESAs (darbepoetin alfa) .
-
Safety and efficacy of low-dose dasatinib in elderly patients with newly diagnosed chronic myeloid leukemia in chronic phase
Time of Update: 2022-04-30
The DASISION clinical trial showed that patients with newly diagnosed CML in the chronic phase treated with the second-generation TKI dasatinib (100 mg/day) had higher rates of major molecular remission and faster remission rates compared with patients treated with the first-generation TKI imatinib Fast; nearly half of patients had deep molecular remissions lasting at least 1 year without relapse after discontinuation of dasatinib .
-
Clin Oncol: Efficacy of FOLFIRI combined with bevacizumab versus FOLFIRI combined with aflibercept in the second-line treatment of metastatic colorectal cancer
Time of Update: 2022-04-23
Recently, the journal Clinical Oncology published the results of a clinical study, mainly in patients with metastatic colorectal cancer (mCRC) who failed first-line oxaliplatin-based chemotherapy, the second-line use of FOLFIRI combined with bevacizumab versus FOLFIRI combined with Efficacy of aflibercept therapy .
-
In-hospital management of patients with thrombocytopenia caused by hematological diseases (1) - immune thrombocytopenia
Time of Update: 2022-02-24
If the maximum dose is ineffective for 2 to 4 weeks, the drug should be discontinued (level A recommendation, Level Ia evidence), individualized maintenance therapy should be performed for those who are effective .
-
Ion exchange membrane and electrodialysis
Time of Update: 2021-12-31
Under the action of a direct current electric field, using the potential difference as the driving force, the selective permeability of the ion exchange membrane is used to separate the electrolyte from the solution to achieve the desalination, concentration and passivation of the solution; the salt can also be achieved by electrodialysis electrolytic preparation of chlorine and sodium hydroxide .
-
Hausen Pharmaceuticals' new adaptation of Ametinib is approved for the first-line treatment of non-small cell lung cancer
Time of Update: 2021-12-26
According to the public information of priority review, the approved indications for this drug are: adults with locally advanced or metastatic non-small cell lung cancer with epidermal growth factor receptor exon 19 deletion or exon 21 (L858R) substitution mutation First-line treatment for patients .
-
LEUKEMIA: Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance treatment for myeloma up to 70 years old
Time of Update: 2021-12-01
German Myeloma Multicenter Group (GMMG)-MM5 is a prospective, multicenter Phase III trial using bortezomib-based IT, pre-MEL200/ASCT and lenalidomide consolidation and maintenance for patients 18 to 70 years old Treatment, an analysis was performed, focusing on progression-free survival (PFS), overall survival (OS), time to progression (TTP), non-relapse mortality (NRM), response rate, and patient age-related toxicity .
-
The mortality rate after this fungal infection is as high as 50%, and it is often necessary to combine antifungal treatment | Case Sharing
Time of Update: 2021-10-11
Figure 2 A lactophenol cotton blue staining revealed transparent septal hyphae with clusters of short conidia; B immunohistochemistry negative for Aspergillus antibodies; C negative immunohistochemistry for Mucor antibodies followed by next-generation metagenomic sequencing (mNGS) The final diagnosis was an invasive lung infection of Trichoderma longibrachiatum .
-
Express | Hope to benefit nearly one-tenth of school-age children, FDA approves the first non-stimulant hyperactivity treatment in ten years
Time of Update: 2021-04-19
▎The content team editor of WuXi AppTec recently, Supernus Pharmaceuticals announced that the US FDA has approved the company's Qelbree (viloxazine sustained-release capsules) to treat attention deficit hyperactivity disorder (ADHD) in pediatric patients aged 6-17.
-
J Sports Med Phys Fitness: Caffeine doesn't change serum testosterone levels during men's exercise
Time of Update: 2020-07-13
This study investigated the effect of caffeine supplementary (CAF) coffee intake on the exercise response of serum testosterone (T) in men trained in exercise intensity subjects consumed 12 ounc
-
Which hospital majors beijing bronchial dilation therapy
Time of Update: 2020-05-13
Our hospital experts suggest that the vast number of bronchial dilation patients to be treated in a timely manner, choose regular hospitals, military hospital experts original "4S clear lung flat asthma therapy" clinically verified to successfully cure tens of thousands of bronchial dilation patients, is the ideal treatment for the vast number of patients For more information, please click on the inquiry
